(MedPage Today) — Clinicians should be on alert for signs of medetomidine exposure and withdrawal in suspected overdose cases, public health experts said Thursday during a CDC webinar.
Hosted by the agency’s Division of Overdose Prevention, the…
Source link : https://www.medpagetoday.com/publichealthpolicy/publichealth/116893
Author :
Publish date : 2025-08-07 21:19:00
Copyright for syndicated content belongs to the linked Source.
